Novartis Venture Fund
Patricia McGovern is an accomplished regulatory affairs professional with extensive experience in the pharmaceutical industry. Currently serving as Vice President of Innovation Regulatory Affairs at Novartis since December 2018, Patricia oversees regulatory support for digital medicine, including software as a medical device, artificial intelligence/machine learning, and blockchain initiatives. Prior to this role, Patricia held various leadership positions at Novartis from December 1991 to January 2018, including Global Head of Digital Medicine and Devices and Global Therapeutic Area Lead for multiple therapeutic areas. Patricia began her career as a Chemistry Manager at PTRL from 1988 to 1990. Educated at Barnard College with an AB in chemistry and the University of California, Berkeley, where Patricia completed PhD research in chemistry, a strong academic foundation supports Patricia's professional achievements.
This person is not in any teams
This person is not in any offices
Novartis Venture Fund
3 followers
Novartis Venture Fund's primary focus is on the development of novel therapeutics and platforms. In their investments, they look for unmet need and clinical impact, novel proprietary science, and understanding of the mechanism, management, and board experience and capital efficiency in the program.